PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted ...
Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
While rare, the fungal infection mucormycosis can be fatal. It tends to impact individuals who are immunocompromised or who have diabetes. This fungus can grow into blood vessels, destroying tissue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results